Equities

Modalis Therapeutics Corp

4883:TYO

Modalis Therapeutics Corp

Actions
  • Price (JPY)143.00
  • Today's Change2.00 / 1.42%
  • Shares traded18.16m
  • 1 Year change+10.00%
  • Beta0.8423
Data delayed at least 20 minutes, as of Nov 25 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(2391)(2707)(745)
Depreciation/depletion0.7312478
Non-Cash items41678(487)
Cash taxes paid, supplemental1.211.211.21
Cash interest paid, supplemental4.416.13--
Changes in working capital949.51407
Total cash from operations(2254)(1896)(747)
INVESTING
Capital expenditures(40)(197)(107)
Other investing and cash flow items, total--12279
Total cash from investing(40)(186)172
FINANCING
Financing cash flow items(6.85)(0.91)0.00
Total cash dividends paid------
Issuance (retirement) of stock, net7417173
Issuance (retirement) of debt, net482(6.75)--
Total cash from financing1,2166473
NET CHANGE IN CASH
Foreign exchange effects281518
Net change in cash(1050)(2003)(485)
Net cash-begin balance/reserved for future use2,9334,9365,421
Net cash-end balance/reserved for future use1,8832,9334,936
SUPPLEMENTAL INCOME
Depreciation, supplemental0.7312478
Cash interest paid, supplemental4.416.13--
Cash taxes paid, supplemental1.211.211.21
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.